Viral infection is one of the leading medical challenges of the 21st century, ranging from the hepatitis C virus (HCV) epidemic affecting 3 percent of the global population, to recent outbreaks of West Nile, Zika and Ebola viruses.
Live fluorescent imaging of hepatitis C viruses (red) seemingly avoiding liver cells that accumulate fat (green) in spite of the virus's well known contribution to fatty liver disease. Courtesy of Yaakov Nahmias
Viral infection is one of the leading medical challenges of the 21st century, ranging from the hepatitis C virus (HCV) epidemic affecting 3 percent of the global population, to recent outbreaks of West Nile, Zika and Ebola viruses.
Viruses are parasites that lack the basic metabolic machinery needed to replicate. To get around this problem, they hijack the metabolic machinery of their hosts in order to complete their lifecycle and propagate. However, scientists still don't have a good understanding of the metabolic interplay between viruses and the organisms they infect. This is mainly due to the complex interplay between human genes and metabolic processes.
Now, in new research appearing in the journal Nature Chemical Biology, an international research group led by the Hebrew University of Jerusalem systematically identified an array of genetic switches that controls the metabolic response to hepatitis C virus infection. By carefully selecting drugs that target these genetic switches, the researchers were able to show how these genes control metabolic processes, such as glucose and lipid metabolism, and establish how these processes affect the virus lifecycle. Surprisingly, while some metabolic processes were beneficial for the virus, for example by providing it with building blocks for its genetic material allowing it to replicate faster, other metabolic processes were surprisingly anti-viral, disturbing the viral lifecycle.
"This is the first indication that our cells can block replication of Flaviviridae viruses like HCV and Zika by denying them from critical building blocks the viruses need to survive," said Yaakov Nahmias, director of the Alexander Grass Center for Bioengineering at the Hebrew University of Jerusalem, who led the study. "Our results present a new approach to treat virus infection by targeting the genetic regulation of metabolic processes on which the virus rely."
Metabolism is a complex phenomenon that is primarily regulated by genetic switches called nuclear receptors. Nuclear receptors are a family of proteins found within cells that are activated by metabolites such as fatty acids or glucose, acting as sensors that allow cells to sense and respond to changes in nutrition (e.g. breakfast) by regulating the expression (i.e. activation) of hundreds of genes.
Viruses such as HCV can interfere with this metabolic regulation. When this happens, it results in fatty liver disease and diabetes in infected patients.
To find the mechanism by which viruses such as HCV can interfere with metabolic regulation, the researchers used a new laboratory model of human liver cells developed by Nahmias. By mapping out the metabolism of both infected liver cells and normal liver cells, they were able to focus on disturbed metabolic processes, and identify the nuclear receptors responsible for their dysregulation.
"This is a fascinating approach," said Oren Shibolet, head of the Department of Gastroenterology at Tel Aviv Sourasky Medical Center and Tel-Aviv University and a co-author of the study, "as the same methodology can be applied to study the metabolic regulation of liver cancer and other infections to possibly identify new therapeutic targets."
Once the researchers identified the genetic switches controlling the disturbed metabolic processes, they blocked each nuclear receptor using pharmaceuticals, and studied the effects of this inhibition on the virus. While blocking glucose metabolism was detrimental to the virus, blocking lipid metabolism had the reverse effect, actually increasing HCV replication. These findings were validated in a small cohort of HCV patients.
The authors point out that the Flaviviridae family of viruses, which includes Hepatitis C, Dengue, West Nile, Yellow Fever, and Zika viruses, were previously considered to be expert metabolic engineers that optimized the hijacking of host metabolic machinery to create more viruses. "It was quite surprising to see that human liver cells could use metabolic processes to resist viral infection," said Jörg Timm, a co-author from the Institute of Virology at the University of Düsseldorf. "It went against our common understanding of viruses as expert metabolic engineers, suggesting new avenues to target virus infection."
Participating institutions include the Hebrew University of Jerusalem, Harvard Medical School, Broad Institute of MIT and Harvard, Tel Aviv University, University Duisburg-Essen, and the University of Düsseldorf.
Source: The Hebrew University of Jerusalem
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.